Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia

Autor: Carmela Gurrieri, Alessandra Brancalion, Marilena Carrino, Elisa Mandato, Gianpietro Semenzato, L Quotti Tubi, Fortunato Zaffino, Livio Trentin, Francesco Piazza, Gianni Binotto, Paolo Macaccaro, Sabrina Manni, Ketty Gianesin, E Doriguzzi Breatta, S Canovas Nunes, Renato Zambello
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Adult
Male
STAT3 Transcription Factor
Cancer Research
Cell Survival
Gene Expression
Leukemia inhibitory factor receptor
Antineoplastic Agents
Immunophenotyping
03 medical and health sciences
Promyelocytic leukemia protein
0302 clinical medicine
Adenosine Triphosphate
Cancer stem cell
hemic and lymphatic diseases
Cell Line
Tumor

medicine
Humans
Casein Kinase II
Protein Kinase Inhibitors
Aged
Cell Proliferation
Aged
80 and over

Polycomb Repressive Complex 1
biology
Cell Cycle
Forkhead Box Protein O3
NF-kappa B
Myeloid leukemia
Hematology
Middle Aged
medicine.disease
Haematopoiesis
Leukemia
Leukemia
Myeloid
Acute

030104 developmental biology
Oncology
Drug Resistance
Neoplasm

030220 oncology & carcinogenesis
Cancer research
biology.protein
Neoplastic Stem Cells
Female
Stem cell
Leukemia inhibitory factor
Proto-Oncogene Proteins c-akt
Biomarkers
Signal Transduction
Zdroj: Europe PubMed Central
Popis: Protein kinase CK2 sustains acute myeloid leukemia cell growth, but its role in leukemia stem cells is largely unknown. Here, we discovered that the CK2 catalytic α and regulatory β subunits are consistently expressed in leukemia stem cells isolated from acute myeloid leukemia patients and cell lines. CK2 inactivation with the selective inhibitor CX-4945 or RNA interference induced an accumulation of leukemia stem cells in the late S-G2-M phases of the cell cycle and triggered late-onset apoptosis. As a result, leukemia stem cells displayed an increased sensitivity to the chemotherapeutic agent doxorubicin. From a molecular standpoint, CK2 blockade was associated with a downmodulation of the stem cell-regulating protein BMI-1 and a marked impairment of AKT, nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3) activation, whereas FOXO3a nuclear activity was induced. Notably, combined CK2 and either NF-κB or STAT3 inhibition resulted in a superior cytotoxic effect on leukemia stem cells. This study suggests that CK2 blockade could be a rational approach to minimize the persistence of residual leukemia cells.
Databáze: OpenAIRE